|
|
|
$70M Pfizer Drug Account Under Review
|
Business New Haven
9/01/2003
By: BNH
|
NEW LONDON — At press time the advertising account for Pfizer Inc.’s arthritis product Celebrex was under review, with a decision due presently. According to Adweek, J. Walter Thompson in New York was the account incumbent, with leading contenders said to be Arnold and the Kaplan Thaler Group, both of New York.
|
Go FirstGo PreviousGo
NextGo LastGo
to Index
|
|
